Study looks at nicotine gum, smoking cessation
This article was originally published in The Tan Sheet
Executive SummarySmokers who began nicotine gum treatment four weeks prior to a target date to quit smoking were no less likely to stop smoking or experience withdrawal symptoms than subjects who started using the gum on their quit date, according to a Swiss study. Researchers led by Jean-Francois Etter, of the University of Geneva's Institute of Social and Preventive Medicine, hypothesized that pre-cessation treatment with gum would be more effective than post-cessation treatment because they "thought that obtaining nicotine from gum instead of cigarettes would weaken cigarette reinforcement." The researchers write in a report published June 8 in the Archives of Internal Medicine that the 314 daily smokers studied might have had better success with additional face-to-face counseling or with a nicotine patch, which maintains a steady level of the drug in the bloodstream. Although the study results dispute the status of nicotine gum as a "cut down to quit" product in many countries, the researchers say there remains "a need to explore strategies to increase the reach and efficacy" of nicotine replacement therapies
You may also be interested in...
US medtech companies are worried EU notified bodies have too much freedom over setting their fees, accusing them of lacking transparency and being inconsistent with what they charge. They also allege that notified body practices mean some products will miss the four-year grace period.
For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?